| News
Japanese company opens R&D centre in Basel
25.01.2017
Idemitsu Kosan is a Japanese petroleum company, but it also develops and manufactures electronic materials. The company is now opening a research and development centre for organic light-emitting diodes in Basel, its first outside of Japan.

Panorama Basel (img: Andreas Zimmermann)
Considerable advances have been made in the use of OLED (organic light-emitting diodes) displays in numerous products, including smartphones and large-screen televisions. For this reason, Idemitsu Kosan has decided to enhance its development capacity in this field by establishing an OLED materials development company in Basel. Idemitsu OLED Materials Europe AG, which is opening in January, will be the company’s second OLED R&D facility. The first is in the city of Sodegaura in Japan, explains the company in a statement.
Idemitsu has been cooperating with BASF Schweiz AG in the OLED field, and the OLED researchers from BASF will now work for Idemitsu in the canton of Basel-Stadt. Switzerland is an ideal location for the new R&D centre because it is a global leader in fine chemical synthesis, which is when compounds or new materials are developed out of elements. Researchers from diverse technical backgrounds will develop Idemitsu’s OLED technology in Basel, thus strengthening this business area.
The location promotion organisation BaselArea.swiss assisted Idemitsu in the search for a suitable location.
Share this article
Sign up to receive our newsletter in your inbox.
You might also be interested in
Evolva launches new line for manufacturers of personal care products
Evolva, a manufacturer of active ingredients based in Reinach in the canton of Basel-Landschaft, will be presenting its new product...
Read MoreRecord figure for startups in the Basel Area
Basel Area Business & Innovation has supported a record number of 96 company startups in 2022. The number of settlements...
Read MoreNoema Pharma raises 103 million Swiss francs from investors
Noema Pharma has raised a total of 103 million Swiss francs as part of an oversubscribed Series B financing round....
Read MoreWhy CDMO companies choose the Basel Area as their location
Originally, this article was published by the US magazine Outsourced Pharma under the title "Why Location Matters". The article highlights...
Read MoreBasel still the most attractive small city for business in Europe
As with last year, Basel once again features among the most attractive locations in Europe for investments. It was ranked...
Read MoreAriceum Therapeutics establishes subsidiary in Basel
The German life sciences firm Ariceum Therapeutics has established a subsidiary in Basel. This company has received support from Basel...
Read MoreRocketVax raises fresh capital
The Basel-based biotech startup RocketVax has successfully closed another financing round. This additional funding will primarily be used to further...
Read MoreClinerion is now part of Citeline
Clinerion has been integrated into New York-based company Citeline. Clinerion plans to expand its portfolio with Citeline’s complementary opportunities with...
Read MoreKUORI developing biodegradable plastics
The Basel-based cleantech company KUORI GmbH develops alternative materials for conventional plastics. The aim is to reduce the accumulation of...
Read MoreCell and gene therapies gain momentum in Basel
Companies specializing in the research and development of innovative cell and gene therapies continue to spring up all around the...
Read More